HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
PEPFAR committed to work with countries on a system of shared data and rotating locations for implementation studies; to develop a proposal for further expediting the regulatory approval process; and to fund the procurement of only optimal paediatric ARVs.
-
-
-
-
To fund the procurement of only optimal paediatric ARVs.
-
see action 9.
-
-
-
-
-
-
-
-
-
-
-
-
-
PEPFAR committed to work with countries on a system of shared data and rotating locations for implementation studies
-
PEPFAR has developed a website that makes program data available for review and analysis: https://data.pepfar.net/ PEPFAR is developing a mechanism for addressing requests from external stakeholders and partners for more detailed program data to use in important analyses.
PEPFAR has not yet developed sites for implementation studies.
-
-
-
-
-
-
-
-
-
PEPFAR
Sub-Actions & Milestones
PEPFAR and FDA have been working on mechanisms that would enable making FDA review documents available to WHO and/or national drug regulatory authorities for tentatively approved products to facilitate more timely regulatory approval of those products for use in PEPFAR-supported HIV programs.
PEPFAR has also been working with WHO in advance of the upcoming WHO Guidelines meeting to advance optimal ARV regimens for children.
-
-
To develop a proposal for further expediting the regulatory approval process
Updates
Notes
Responsible